Proceedings of the International scientific and practical conference ―Current Issues in Science‖ (January 9-11, 2026) / Publisher website: www.naukainfo.com. – Dresden, Germany, 2026. – 179 p.

65 specialists that patients with initial signs of nail changes consult. Insufficient awareness of the possible combination of psoriasis and onychomycosis can lead to late diagnosis and irrational treatment, which further increases the burden on specialized care. The introduction of routine mycological screening in patients with nail psoriasis, especially before prescribing systemic or biological therapy, should be considered an effective tool for preventing complications and optimising healthcare resources. This approach reduces the number of cases of fungal infection progression against the background of immunosuppressant, decreases the frequency of therapeutic failures and the need for treatment correction. From an organizational point of view, it is advisable to develop standardized algorithms for the management of patients with psoriatic nail lesions, which would include a mandatory stage of mycological diagnosis. Integrating these algorithms into patient care pathways will help improve the quality of medical care, reduce regional differences in practice, and improve the reproducibility of clinical results. The issue of medical education [14] and professional development of doctors deserves special attention. Expanding knowledge about the poverty comers of nail psoriasis and onychomycosis, modern diagnostic approaches and risks associated with immunosuppressive therapy is an important component of preventing diagnostic errors. This is important not only for dermatologists, but also for primary care physicians and related specialties. Thus, considering the poverty gap in nail psoriasis and onychomycosis from a public health perspective justifies the need for a systematic approach to the diagnosis and management of this category of patients. The combination of clinical vigilance, laboratory confirmation of the diagnosis, and organizational decisions at the healthcare system level contributes to increased treatment effectiveness, reduced economic burden, and improved long-term outcomes for patients and society as a whole.